LobbyingLantheus Holdings lobbying by quarter
Lantheus Holdings LNTH's latest lobbying report covers Q2 2026, at $392K. The four quarters Q3 2025–Q2 2026 total $902K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
- Latest quarter
- $392K
- Q2 2026 · 2 reports
- Last 12 months
- $902K
- Last 4 quarters
- vs last quarter
- +0.5%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $75K | 1 |
| Q1 2023 | $290K | 1 |
| Q2 2023 | $110K | 1 |
| Q3 2023 | $70K | 1 |
| Q4 2023 | $70K | 1 |
| Q1 2024 | $460K | 2 |
| Q2 2024 | $215K | 2 |
| Q3 2024 | $200K | 2 |
| Q4 2024 | $190K | 2 |
| Q1 2025 | $480K | 2 |
| Q2 2025 | $60K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $390K | 2 |
| Q2 2026 | $392K | 2 |
Policy issues the reports name
- Medicare and Medicaid20 reports
- Health issues5 reports
- Budget and appropriations4 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES20 reports
- SENATE20 reports
- Centers For Medicare and Medicaid Services (CMS)11 reports
- White House Office4 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseLantheus Holdings | $2.5M | 12 quarters |
| Tarplin, Downs & Young | $600K | 10 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHARLOTTE SPEARS IVANCIC | Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner | Q2 2026 |
| MARGARET JOSEPH | CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. | Q2 2026 |
| PETER FISE | Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $332K |
| 07/20for Q2 | Tarplin, Downs & Young | $60K |
| 04/20for Q1 | In-house | $330K |
| 04/20for Q1 | Tarplin, Downs & Young | $60K |
| 01/30for Q1 | In-house | Under $5,000 |
| 01/20for Q4 2025 | Tarplin, Downs & Young | $60K |
| 25/10/15for Q3 2025 | Tarplin, Downs & Young | $60K |
| 25/08/05for Q1 2025 | In-house | $420K |
| 25/07/17for Q2 2025 | Tarplin, Downs & Young | $60K |
| 25/04/21for Q1 2025 | Tarplin, Downs & Young | $60K |
| 25/03/31for Q1 2025 | In-house | $420K |
| 25/01/16for Q4 2024 | Tarplin, Downs & Young | $60K |
| 25/01/16for Q4 2024 | Tarplin, Downs & Young | $60K |
| 25/01/09for Q4 2024 | In-house | $130K |
| 24/10/18for Q3 2024 | Tarplin, Downs & Young | $60K |
| 24/10/15for Q3 2024 | In-house | $140K |
| 24/07/16for Q2 2024 | Tarplin, Downs & Young | $60K |
| 24/07/12for Q1 2024 | In-house | $400K |
| 24/07/01for Q2 2024 | In-house | $155K |
| 24/04/16for Q1 2024 | Tarplin, Downs & Young | $60K |